Active Ingredients
6.2 mg estradiol 0.5 water
Excipients
Pegoterat
Soybean oil, refined
Poly[(2-ethylhexyl)acrylate-co-methylacrylate-co-acrylic acid-co-(2,3-epoxypropyl)methacrylate] (62.2:32:5.7:0.03)
Preparation of (R,R,R)-α-tocopherol
ESTRAMON 75 mcg/24 hours transdermal patches
The active ingredient is one of the body’s own estrogens. They are crucial for the function of the female reproductive organs. Estrogens, among other things, cause the cyclic growth of the uterine lining, increase its viscosity, promote bone formation, and suppress ovulation and milk production. They continue to have an antiandrogenic effect, are able to compensate for the lack of estrogen in women during menopause and alleviate cycle disorders.
Areas of use
Hormone replacement therapy (HRT) for estrogen deficiency syndrome during menopause
– prevention of osteoporosis during menopause (when the use of a drug approved for the treatment of osteoporosis is impossible)
Compound:
Active ingredient: Estradiol 0.5-water (6.198 mg per 30 cm2 patch = 1 patch) = Estradiol (release: 0.075 milligrams per day per 30 cm2 patch = 1 patch); Other Ingredients: Soybean oil, refined poly[(2-ethylhexyl)acrylate-co-methylacrylate-co-acrylic acid-co-(2,3-epoxypropyl)methacrylate] (62.2:32:5.7:0.03 ); (R,R,R)-α-tocopherol preparation, pegoterate
